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Illicit use of prescription stimulants has come to the attention of clinicians, school 
administration, and the judicial system in recent years. Illicit stimulant use is defined as the use 
of prescription stimulants without a legitimate prescription or using stimulants inconsistent with 
the prescribed treatment plan, including diversion and inappropriate administration methods. 
These prescriptions have been known to cause serious side effects when taken incorrectly, yet 
their popularity as “study buddies” among college students has risen. The most current research 
has found that the percentage of undergraduate students abusing stimulants ranges from 8-43%, 
with an average of 17% of students abusing stimulants yearly. This literature review takes a 
comprehensive approach to the issue of stimulant abuse, attempting to give a glimpse into the 
seriousness of this issue. It examines the history and chemical make-up of stimulants, as well as 
the prevalence, motives, risk factors, and consequences of stimulant abuse in undergraduate 
college students. Finally, this paper proposes a three-pronged approach to decreasing stimulant 













Addiction Generation: Stimulant Abuse in College Students 
 In 2017 the United States Department of Health and Human Services declared the opioid 
epidemic a public health emergency. An epidemic that claimed more than 500,000 lives ravished 
the nation.  
 The opioid epidemic racked American small towns and created pandemonium in 
metropolitan areas across the country. This crisis took lives, tore apart families, and ultimately 
ignored the physicians responsible for the carnage. The first wave of opioid overdoses began in 
1999, a time when opioids were prescribed at increased rates. Two more waves have occurred 
since. Involving higher-powered opiates. In 2010, there was another spike in overdose deaths 
involving heroin. The most recent spike, in 2013, was attributed to manufactured fentanyl (CDC, 
2021).  The term opioid epidemic is now a household name. In the years following these spikes, 
we have moved from our initial shock and horror to a state of complacency tempered by 
occasional bouts of outrage and reform. However, even with the severity of this issue, it took 18 
years for opioid overdoses to be declared a public health emergency. The opioid epidemic is 
well-known and well-documented, but another epidemic waits for its moment to take center 
stage. This time, we hope to catch it before it becomes a public health emergency.  
A wave of new prescriptions has swept over America.  Drugs such as Adderall, Ritalin, 
Concerta, and Focalin are being prescribed at alarming rates. From 2003 to 2011 the number of 
children aged 4-17 with an ADHD diagnosis and stimulant prescriptions skyrocketed from 4.4 to 
6.4 million (CDC, 2021). These drugs, commonly referred to as stimulants, are prescribed by 
physicians, readily available, and advertised as harmless. However, unlike the opioid epidemic, 
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which focused mainly on 25–44-year old’s (CDC, 2021), this wave of stimulant use targets 18–
29-year old’s (Board et al., 2020).  
Literature Review 
History of Stimulants  
Though Attention Deficient Hyperactivity Disorder (ADHD) prescriptions dominate the 
use of stimulants today, they did not start as a cure for overactive children. The intended use for 
the compound known initially as beta-phenyl isopropylamine was as a decongestant. Chemist 
Gordon Alles discovered the compound now know as amphetamine while attempting to make a 
drug that could rival ephedrine at relieving asthma symptoms. (Rasmussen, 2008). Although he 
had no evidence the drug would effectively cure congestion, he patented amphetamine sulfate 
and amphetamine hydrochloride in 1932 as oral salts (Rasmussen, 2008). Unfortunately, Alles’s 
vision of making the respiratory history books was short-lived. Amphetamines did nothing to 
help asthmatics, but during the human trials of his newly minted drug, he discovered a strange 
set of side effects. Those given amphetamines were unusually alert, their blood pressure climbed, 
and their minds seemed to race. Though he did not know it yet, Alles had just discovered what 
would eventually be the compound’s most significant selling point. (Rasmussen, 2008). 
Alles saw potential in amphetamines but did not have the resources to test its scope. His 
solution was to approach a Philadelphia pharmaceutical company, SKF, about a partnership 
(Hicks, 2021). SKF was already producing a variation of Alles’s amphetamine compound as an 
over-the-counter inhaler and was eager to explore new ways the drug could be used (Rasmussen, 
2008). Alles transferred ownership of the patent to SKF, and a lucrative partnership was born. To 
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truly reach their full potential as a viable option for doctors to prescribe, approval from the 
American Medical Association’s (AMA) was needed. In 1937 amphetamines under the brand 
name Benzedrine Sulfate were given the AMA seal of approval, as no noticeable, severe, 
negative results had been found during human trials. SKF began to advertise the drug 
(Rasmussen, 2008). 
The original plan to use amphetamines to cure asthma symptoms failed, but 
amphetamines were then produced and marketed as a cure-all for narcolepsy and Parkinsons’ 
(Rasmussen, 2008). However, the market for these two conditions was small. Alles and SKF 
capitalized on the “feelings of well-being” (Hicks, 2021) subjects often described when taking 
amphetamines. The drug was next promoted as a cure for mild depression and marketed to 
overworked homemakers. The effects of this shift had long term effects that are still being felt 
today.  
During World War II, the American military began supplying Benzedrine sulfate tablets 
to servicemen for “routine use in aviation, as a general medical supply, and in emergency kits” 
(Rasmussen, 2008, pg. 975). There were regulations on the use of Benzedrine, of course, but 
these were viewed more as suggestions. In 1945, a survey of fighter pilots revealed that 13 out of 
85 pilots used these drugs whenever they felt the urge, not according to medical direction 
(Rasmussen, 2008, pg. 975). This hinted at the potential abuse of Benzedrine to come. Soon, 
consumption of Benzedrine skyrocketed as new uses were found for the pill, including weight 
loss, psychiatric disorders, and as energy enhancers. By the end of 1945, conservative estimates 
place the production of Benzedrine pills at 30 million tablets a month. This was enough to supply 
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half a million Americans with a daily dose of two tablets. (Rasmussen, 2008, pg. 975). It is no 
surprise that given its availability and attractiveness, abuse quickly developed.  
Consumption of amphetamines saw another drastic increase after 1949, following Alle’s 
and SKF’s patent expiration. Amphetamines in various forms were now being prescribed as the 
psychiatric drug of choice. However, this would be challenged by the debut of monoamine 
oxidase inhibitors and tricyclic antidepressants in the 1950s. These drugs were ranked as superior 
by psychiatrists who now understood amphetamines’ addictive properties and hallucinogenic 
side effects. The end of WWII saw a generation of young people addicted to the drug and 
experiencing extreme side effects (Rasmussen, 2008). 
Nevertheless, prescription rates of amphetamines did not drastically decline as expected. 
After a brief foray into the world of antipsychotics, many physicians returned to amphetamines. 
A primary care physician explained in 1970, “only amphetamine kept certain patients “capable 
of performing or even enjoying their duties— that is, of managing their problems of living” 
(Rasmussen, 2008, pg. 978). Vast prescriptions of amphetamines could not continue without 
consequences, and these were made visible in 1970. Law enforcement authorities reported that 
80-90% of amphetamines seized on the street were prescriptions manufactured by U.S. 
pharmaceutical companies (Rasmussen, 2008, pg. 980). These drugs, now commonly referred to 
as speed, because of their energizing effect, could be bought and sold with ease. No longer was a 
prescription necessary, amphetamines had hit the streets.  
It was during this time of rampant abuse, years after their creation, that public officials 
began to do something about the crisis. The Bureau of Narcotics and Dangerous Drugs, 
(predecessor to today’s Drug Enforcement Administration,) and the FDA moved amphetamines 
7 
 
to a Schedule II drug (Rasmussen, 2008). This move from a Schedule III to a Schedule II placed 
limitations on the prescription of amphetamines and thoroughly regulated their use. Schedule II 
drugs require a new prescription for each fill, and doctors and pharmacists must keep careful 
records of dispensation. The FDA enacted limits on the production of amphetamines to minimize 
the supply hitting the market and narrowed its usage to approved disorders. Medical justification 
was now required for a prescription. Narcolepsy and ADHD were the only two disorders that 
remained approved for treatment with amphetamines (Rasmussen, 2008). 
Pharmaceutical companies scrambled to retain their market. They revamped their 
approach and focused on what would become their most lucrative market yet. ADHD was a 
rising star in the world of mental illness. A diagnosis of ADHD was subjective, the doctor could 
fill out a quick questionnaire in the presence of the child and their parent, and 30 minutes later, 
they could leave with a prescription that would “fix” everything. In 2005, usage levels in 
children surpassed those of the previous epidemic at its height in 1970 (Rasmussen, 2008, pg. 
981). American physicians found it difficult to resist prescribing stimulants for their youngest 
patients and their grateful parents, leading to the most recent surge in amphetamine use. This was 
compounded by the newly revised DSM-V manual, which made ADHD the most common 
neurodevelopmental disorder in children. The resulting surge in ADHD diagnoses was 
unprecedented and showed no signs of slowing. In his article, Problems of Overdiagnosis and 
Overprescribing in ADHD, Dr. Daniel Conners attempts to explain this surge. He explains that 
before the 1970s, a diagnosis was rare for children and almost unheard of for adolescents and 
adults (Conners, 2011). Then, between 1980 and 2007, there was an increase in ADHD 
diagnoses, almost eight times as many prescriptions were written and filled compared with the 
rates of 40 years before. (Conners, 2011). 
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Several complex factors in the early 1990s helped increase the popularity of stimulants. 
First, was the growing concern from child welfare advocates and mental health professionals 
over the stigma associated with a mental health diagnosis. Decreasing stigma was vital in 
increasing federal funding for special education programs. In 1990, the Individuals with 
Disabilities Education Act formally recognized ADHD as a disability, and schools were then 
required to make accommodations for students with this diagnosis (Conners, 2011). In addition, 
Congress expanded eligibility for Medicaid, especially for children to include coverage of 
psychopharmaceuticals, including stimulants (Conners, 2011). 
A rapid increase in scientific knowledge about the long-term effects of ADHD was also 
happening at this time. ADHD’s morbidity, neurobiology, and heritability gave grounds for 
researchers to suggest medical interventions. (Conners, 2011). Then in 1997, Congress passed 
the FDA Modernization Act, which encouraged the pharmaceutical industry to develop and test 
drugs intended for pediatric patients by extending their patent exclusivity. The burgeoning field 
of psychiatric healthcare was beginning to carve out its place in the medical realm and agreed 
that many complex psychiatric disorders seen in pediatric patients could and should be treated 
with medications (Conners, 2011). However, this increase in stimulant use was not a standalone 
issue. 
Overview of Stimulant Use  
The illegal use of prescription stimulants is an issue that has plagued America since the 
drug’s conception in 1929 (Rasmussen, 2008). Originally used to fight congested noses, 
stimulants soon became a substance of abuse when American pilots realized their usefulness in 
keeping them alert on long missions. Once introduced to the American military, their misuse 
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spread. Soon, tired housewives and bored office workers used amphetamines to make their days 
more bearable (Rasmussen, 2008). This widespread misuse was just the beginning of a long road 
of abuse for stimulants. Now stimulant misuse centers on students, specifically college students, 
looking to get an edge in today’s competitive academic world.  
Stimulants have become the second most used illicit substance in the United States, 
following closely behind cannabis (Arria et al., 2013; Gomes et al., 2011; Weyandt et al., 2013). 
Rates of illicit use of stimulants by students are reportedly as high as 43% on some college 
campuses (Benson et al., 2015). Inappropriate use of prescription stimulants can have serious 
negative consequences, ranging from minor side effects like sleeping difficulties (Hartung et al., 
2013; McCabe et al., 2014; Mulvihill, 2013; Weyandt et al., 2013) and headaches (McCabe et 
al., 2014; Mulvihill, 2013), to severe consequences such as depression (Benson et al., 2015; 
Chen et al., 2016; Lueck et al., 2019; McCabe et al., 2014), seizures (Haak, 2017; Mulvihill, 
2013), adverse cardiac outcomes (Chen et al., 2016; Haak, 2017; Mulvihill, 2013; Varga, 2012), 
psychiatric comorbidities (Chen et al., 2016; Mulvihill, 2013; Varga, 2012) and even death 
(Chen et al., 2016; Haak, 2017; Mulvihill, 2013; Varga, 2012).  
Stimulant abuse or misuse can be defined in many ways. However, for this paper, 
nonprescription stimulant abuse will be defined as the use of prescription stimulants without a 
legitimate prescription or using stimulants inconsistent with the prescribed treatment plan, 
including diversion and inappropriate administration methods. This literature review attempts to 
give a glimpse into the seriousness of this issue and suggest some interventions that may prove 
helpful in decreasing prescription stimulant abuse.  
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Prescriptions of antidepressants and antipsychotics also rapidly increased during this 
time.  
Chemical Make-Up of Stimulants  
Stimulants have a high potential for abuse because of their chemical makeup.  
Amphetamines and methamphetamines are chemical cousins, separated only by a methyl group. 
(Kish, 2008; Haile, 2012). These compounds act in the brain by elevating the levels of several 
neurotransmitters, namely, dopamine, serotonin, and norepinephrine, by stimulating their release 
from surrounding nerve endings (Kish, 2008; Haile, 2012). Dopamine and serotonin are 
commonly referred to as the ‘feel good’ neurotransmitters. They are involved in the brain’s 
reward response system, whose sole purpose is keeping us alive. This system naturally releases 
small amounts of dopamine and serotonin during activities like drinking, eating, and exercising. 
This system is the brain’s way of promoting activities that keep us healthy. This system can also 
be activated by dopamine and serotonin agonists, such as methamphetamines and amphetamines. 
When these substances are consumed, the cell receptors are damaged and cause excessive 
amounts of dopamine and serotonin to be release, resulting in the artificial high the consumer 
craves (Kish, 2008; Haile, 2012).  
Methamphetamines are notorious for the speed at which they cross the blood-brain 
barrier. In more recent research, it has been discovered that methamphetamine damages the 
structural proteins in the blood-brain barrier and increases the barrier’s permeability to other 
molecules. Over time, this decreased protection leads to the accumulation of toxins in the brain, 
one of the key findings in long-term methamphetamine users (Northrop & Yamamoto, 2015). By 
damaging the receptors, methamphetamine and amphetamines prevent serotonin and dopamine 
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from being reabsorbed in the typical fashion. This results in a longer half-life as the body cannot 
clear the drug from the system as quickly (Kish, 2008). The half-life of methamphetamine is 10-
12 hours, which is very dangerous when paired with many consumers’ tendency to binge the 
drug, repeatedly dosing over 1-3 days. The accumulation in the body is toxic and eventually 
leads to overdose and death (Kish, 2008). 
 Similar to their chemical cousin, amphetamines have a half-life of 10-12 hours. This can 
lead to severe consequences when the drug is not taken as medically directed. At this point, it is 
not well-understood how certain chemical compounds force the release of neurotransmitters, but 
the effects of these compounds are well documented. Side effects are the same one’s 
amphetamine users experience, albeit not as intense. Amphetamines cross the blood-brain barrier 
to reach their intended targets but at a much slower rate. The methyl group attached to 
amphetamines slows down the speed at which the compound crosses the blood-brain barrier, 
preventing the user from experiencing the full ‘high’ that methamphetamine users often do 
(Kish, 2008; Haile, 2012). This can be circumvented by taking higher quantities of 
amphetamines, something we have seen becoming more common in recent years (Benson et al., 
2015).   
The similarities of methamphetamine and amphetamines extend into their side effects as 
well. They share a mechanism of action and produce similar results in those using them. The 
typical behavioral effects of methamphetamine include alertness, wakefulness, increased energy, 
a feeling of well-being, euphoria at high doses, and suppression of appetite (Kish, 2008 pg. 
1680). Methamphetamine also causes activation of the cardiovascular and sympathetic nervous 
systems, resulting in increased heart rate and blood pressure, the usual cause of death in 
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overdoses. In more extreme cases, when methamphetamines are abused repeatedly, they can 
cause euphoria, hypersexuality, auditory, visual, and tactile hallucinations, and delusions, and 
psychosis. (Kish, 2008; Haile, 2012).  In cases where methamphetamine has been abused for 
years, severe side effects such as suicidal ideation, depression, and drug-induced schizophrenia 
can occur (Kish, 2008; Haile, 2012).   
Amphetamines bear some of the same side effects as methamphetamines. When taken as 
directed, these compounds also increase wakefulness, produce a feeling of euphoria, increase 
focus and productivity, and suppress appetite. When abused, these drugs can lead to mood 
swings and aggression, paranoia, hyperactivity, increased heart rate, and blood pressure, and 
visual and audible hallucinations (Kish, 2008; Haile, 2012).  These often-pleasurable side effects 
contribute to the levels of abuse we are seeing in college students today. However, many are not 
aware of the risks when taking these compounds without a prescription or genuine need. The 
following section explores the prevalence of illicit stimulant use and what this means for those 
trying to stop illegal stimulant use. 
Prevalence of Illicit Stimulant Use in College-Aged Students 
 The prevalence of licit and illicit stimulate use is a widely debated issue. The most 
current research suggests that the percentage of undergraduate college students aged who abuse 
stimulants ranges from 8%-43% (Benson et al., 2015). This is a vast range, and many factors 
play into the percentage of students using stimulants illegally including things like geographical 
location, Greek presence on campus, and school demographics can influence the number of 
students who use stimulants illegally. There are also methodological differences between the 
studies that may impact their results. In order to understand the nationwide prevalence of 
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stimulant use, it is crucial to have research that addresses different types of four-year colleges, 
universities, and trade schools. A meta-analysis published in the Clinical Child and Family 
Psychology Review by Benson et al. (2015) examined 30 articles and studies that measured the 
prevalence of stimulant abuse in college students from all over the Nation.  
They started by searching various peer-reviewed databases with terms like “abuse of 
ADHD medication,” “abuse of stimulant medication,” and “college students” (Benson et al., 
2015 pg. 52). This search resulted in 727 articles. This initial 727 were narrowed down after 
reading the articles’ titles looking at relevance, and 81 articles were kept. The abstracts for these 
articles were carefully read to determine their applicability and relevancy. These 81 articles had 
to pass five inclusion criteria points to make it into the final 30. The main focus of the article had 
to be the illicit use of ADHD medications. It had to be peer-reviewed, empirical, and use 
quantitative data analytic techniques (Benson et al., 2015 pg. 52). The articles must be written in 
English, only study undergraduate students, and could not focus on one type of ADHD 
medication for the risk of excluding relevant populations. If the article discussed multiple types 
of illicit drug use, the results had to be divided and interpreted individually to give unbiased data 
(Benson et al., 2015 pg. 52). 
Once they had their 30 articles, they began to interpret the data from each study and 
compare the varying rates reported. After a comprehensive review of all articles, the average 
percentage of students who abuse stimulant medications ranges from 8%-43%, with the average 
being 17% (Benson et al., 2015 pg. 52). This is a much more significant percentage than 
acceptable, and the system that has allowed this needs reevaluation.  
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First, ease of access has played a significant role in helping those who intend to abuse 
stimulants get their hands on them. The most commonly cited source student get their stimulant 
medications without a prescription is from friends (Benson et al., 2015; Garnier-Dykstra et al., 
2012; Haak & Keller, 2017; Varga, 2012). One of the studies included in the Benson et al. 30 
study analysis asked students to report whom they had gotten their medication from. The largest 
group, at 39%,  said they bought them off a prescription holder, followed by 36% reporting a 
prescription holder gave them the medications, and 12% admitted buying stimulants from a 
nonprescription holder (Benson et al., 2015 pg. 60). With this in mind, we may need to tailor our 
approach to educating the legal prescription holders on the consequences of their actions. 
Introducing policies and interventions that target high school and college-aged prescriptions 
holders could help decrease the diversion of stimulants (Benson et al., 2015 pg. 60). 
When students are not buying, stealing, or being given prescription stimulants by a 
prescription holder, they may try to get their own prescription. In his comprehensive literature 
review on Adderall abuse on college campuses, Varga (2012) explains that the simplified 
diagnostic process for ADHD may make it tempting for students to fake a diagnosis to get a 
prescription.  According to the fifth edition of the Diagnostic and Statistical Manual of Mental 
Disorders, diagnosing ADHD inattentive type requires the student to meet a few criteria. The 
criteria listed below are what greet the student when being assessed for ADHD. 
Displays poor listening skills, loses and/or misplaces items needed to complete activities 
or tasks, sidetracked by external or unimportant stimuli, forgets daily activities, 
diminished attention span, lacks ability to complete schoolwork and other assignments or 
to follow instructions, avoids or is disinclined to begin homework or activities requiring 
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concentration, fails to focus on details and/or makes thoughtless mistakes in schoolwork 
or assignments. (American Psychiatric Association, 2013).  
 If a student answers ‘yes’ to five or more questions, they are considered inattentive type 
ADHD. Arguably, every college student meets these criteria. A student seeking a prescription 
does not even have to stress their moral compass to qualify for treatment. They can walk out of 
the doctor’s office with a prescription for Adderall that day. This ease of accessibility is 
sometimes tempered by a doctor’s unwillingness to prescribe large amounts of prescription 
stimulants at one time. Students often get around this safety concern by engaging in the practice 
of “doctor shopping” (Chen et al., 2016; Varga, 2012). Doctor shopping is the practice of visiting 
several doctors with the intent to obtain prescriptions from each one. Once the student has these 
prescriptions in hand, they fill them at multiple pharmacies to avoid suspicion (Varga, 2012). 
The only deterrent to this method is that most insurance companies will only pay for a 30-day 
supply of controlled substances at one time. To bypass this roadblock, many students will claim 
they do not have insurance and pay the ticket price for their second or third prescription (Varga, 
2012).  
Motives for stimulant use 
The motives for stimulant use can vary from person to person. Some report using 
stimulants to lose weight or get high, but the reasons typically revolve around academic 
achievements. (Benson et al., 2015; Garnier-Dykstra et al., 2012; Varga, 2012). According to 
Varga (2012), the reasons behind stimulant use include academic pressure, collegiate lifestyle, 
socio-cultural factors, and accessibility (Varga, 2012).  Accessibility was discussed previously, 
so we now turn to the other three factors.   
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First, this pressure to achieve academically stems from parental expectations, competing 
with peer groups, meeting collegiate admissions standards, and personal academic expectations 
(Varga, 2012). The pressure of coping with the fast pace of college life may also contribute to 
students’ use of stimulants. An article published in the Journal of Attention Disorders explains 
that “ADHD symptoms of the newly diagnosed college student may be highly contextual and 
time specific and represent a normal response to temporarily increased demands on intellect and 
motivation” (Diller, 2010).  
Diller explains that many college students who believe they need stimulants to achieve an 
average level of functioning are just experiencing a normal response to the stressors of college 
life (Diller, 2010). However, this normal response could be detrimental to a student’s academic 
career and produce life-altering consequences. Many of the students who turn to stimulants 
earned high marks in high school with relative ease (Varga, 2012). When they are slammed with 
the reality of balancing studies, extracurricular activities, and potentially a job, this 
straightforward approach to academics no longer works. Parents who are often paying for their 
child’s education expect a certain level of performance from their offspring and cannot accept 
mediocracy (Benson et al., 2015; Garnier-Dykstra et al., 2012; Varga, 2012). While they have 
the best intentions, the pressure parents place on their children to achieve academic greatness is 
interpreted by overworked students as one more mountain they must climb. College students 
may feel forced to abuse stimulants to cope with the mounting pressure and anxiety (Varga, 
2012).  
The commonly held belief among many college students is that these drugs are cognitive 
enhancers. Much like how an athlete may use anabolic steroids to improve physical strength, 
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students view stimulants as “brain steroids” that enhance their cognitive prowess. Smith & 
Farah’s (2011) article in the Psychological Bulletin points out that stimulants are not magic pills. 
They hold no cognitive enhancement capabilities such as improving memorization or attention 
span. Students who abuse these drugs may experience a placebo effect, or the drugs themselves 
might alter a student’s perception of the quality of work and the amount done under the influence 
(Smith & Farah, 2011). These drugs enhance wakefulness, motivation, and energy, which could 
improve a student’s ability to do mundane tasks, but their cognitive capabilities remain 
unchanged (Smith & Farah, 2011). 
A study published by Addictive Behaviors disproves the widely held belief that stimulants 
give students an academic edge (Arria et al., 2017). This study found that students who abstained 
from abusing stimulants during their first two years of college show a steady increase in GPA 
from their freshman to sophomore year. Those who abused stimulants consistently during the 
two years did not have an increase in GPA, and some showed a decline (Arria et al., 2017). This 
could be because those who abuse stimulants often skip classes, fail to turn in assignments, and 
then use stimulants to try and compensate before test days to make up for the deficits in their 
grades (Arria et al., 2017).  
The second contributing factor to stimulant abuse is the collegiate lifestyle (Varga, 2012). 
After high school, students may be told that college will be the best years of their lives. This 
refrain is echoed repeatedly as orientation approaches, and many students feel pressured to make 
their college years even more impressive than their high school careers. Resumé building 
becomes the sole focus of getting involved with extracurricular clubs and events. Students are 
expected to enjoy the constant busyness, and many feel guilty if they do not participate in every 
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opportunity. The cycle of late-night parties, all-night studying, rigorous academic and 
extracurricular expectations, and perhaps a job could leave students feeling overwhelmed. Varga 
(2012) points out that this can cause burnout and exhaustion, and stimulants suddenly become a 
viable and attractive option (Kadison, 2005).  
Finally, socio-cultural factors play into the problem of stimulant abuse (Varga, 2012).   
advertisements (Applequist & Ball, 2018). 16% gave information about the conditions targeted 
by the drug, such as prevalence and risk factors, leaving an astounding 84% of advertisements 
not addressing the conditions they are attempting to treat (Applequist & Ball, 2018). ADHD 
medication commercials are not immune to this phenomenon, and many advertisements focus on 
the positive academic consequences of taking stimulants.  
With these four factors at play, it is little surprise that America has developed a stimulant 
addiction. These motives for use are widespread; almost every college student has been exposed 
to these pressures. What is not always equal across the board is the risk factors that many 
students have that may predispose them to use stimulants.  
Risk Factors for Stimulant Abuse  
Like many other addictions and illegal behaviors, several things predispose a person to 
use stimulants illicitly. The prevalence of substance abuse can vary greatly depending on the 
geographic region and competitiveness of the school. However, regardless of the rates of 
stimulant abuse, the risk factors remain relatively constant. While researchers often vary about 
the minute details of what predisposes a person to stimulant use, almost all studies have reported 
several key risk factors. Arria et al. (2013), found socioeconomic status could be a risk factor for 
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stimulant abuse. The mean family income was much higher for students who showed consistent 
stimulant abuse (Arria et al., 2013). This could be due to several things. Students from a higher 
socioeconomic background are often familiar with the medical system and have greater access to 
care and services. They may also have the funds to procure illicit substances and generally would 
not have severe consequences if caught with them (Patrick et al., 2012). Certain substances are 
associated with a higher socioeconomic class, such as alcohol, marijuana, and stimulants. 
In contrast, smoking and methamphetamine use is associated with lower socioeconomic 
status (Patrick et al., 2012). This may also be due to the perceived ‘wrongness’ of certain 
substances. As previously stated, stimulants are viewed as safe and legal with minimal 
consequences for using them without a prescription (Applequist & Ball, 2018; Benson et al., 
2015; Chen et al., 2016; Varga, 2012). Other substances, such as methamphetamines and 
nicotine, may be viewed as more wrong by those of higher socioeconomic status leading to lower 
usage of those specific substances (Patrick et al., 2012). 
Other risk factors include race and gender. Caucasian and Asian ethnicities have the 
highest rates of stimulant abuse compared with Mexican and African American populations  
(Arria et al., 2015; Benson et al., 2015; Haak, 2017; Mulvihill, 2013). Males are also much more 
likely to use stimulants illicitly than females. (Benson et al., 2015; Haak, 2017; Mulvihill, 2013). 
This could be because males often have more sensation-seeking tendencies, which in and of 
itself is a risk factor for stimulant abuse (Benson et al., 2015; Lueck et al., 2019). It could also be 
attributed to higher numbers of males diagnosed with ADHD, leading to a larger pool of 
potential sellers for male users (Benson et al., 2015). Whatever the reason, the results are 
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consistent, reporting that, on average, male stimulant abuse is 9% higher than female stimulant 
abuse (Benson et al., 2015).  
Greek life involvement is also consistently reported as one of the main risk factors for 
stimulant abuse. (Benson et al., 2015; Haak, 2017; Hartung et al., 2013; Mulvihill, 2013). 
However, Garnier-Dykstra et al. (2012) suggest that it is not Greek life specifically that leads to 
increased stimulant abuse, but a pattern of drinking and partying synonymous with Greek life. 
This is cohesive with reports of substance use disorders factoring into a person’s propensity to 
abuse stimulants (Arria et al., 2013; Benson et al., 2015; Garnier-Dykstra et al., 2012; Hartung et 
al., 2013; Lueck et al., 2019). In the meta-analysis done by Benson et al. (2015), 16 of the 30 
studies examined the relationship between substance use disorders and stimulant abuse. All 16 
found a positive correlation between stimulant abuse and other substance abuse disorders. The 
most commonly abused substances were marijuana and alcohol (Arria et al., 2013; Benson et al., 
2015; Garnier-Dykstra et al., 2012; Hartung et al., 2013).   
Low grade point average (GPA) is also a risk factor for stimulant abuse, although the 
reasons why are debated. The first argument is that if a student uses stimulants to compensate for 
their lack of preparation, we will see an expected dip in GPA. This means that a low GPA itself 
is not a risk factor but an indicator that there is an issue in the student’s personal life leading to a 
lower GPA (Arria et al., 2013). This dip in GPA does not necessarily need to be associated with 
an active social life. It could be associated with the ordinary busyness of college life. Regardless 
of the reason, students find little time to prepare for significant assignments and turn to 
stimulants to help them cope (Garnier-Dykstra et al., 2012). The second argument is that students 
who are academically challenged and already have a low GPA will use stimulants to try and give 
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themselves the boost they need (Benson et al., 2015). Both arguments have merit, but the first 
argument seems more compelling with the other known risk factors.  
Lastly, a student’s mental health can play a significant role in whether or not they engage 
in stimulant abuse. Perfectionism, impulsivity, and sensation-seeking are all risk factors for 
stimulant abuse (Benson et al., 2015; Garnier-Dykstra et al., 2012; Haak, 2017; Lueck et al., 
2019).  Depression is also linked to increased stimulant abuse (Lueck et al., 2019). The 2015 
meta-analysis reports that “Symptoms of depression are related to misuse of stimulant 
medication among college students; however, directional effects have not been adequately 
examined” (Benson et al., 2015). Put simply, we know that depression and stimulant abuse are 
linked, but we still do not understand which one influences the other.  
Students abusing stimulants are more likely to feel sad, depressed, and consider suicide 
than their nonusing classmates (Benson et al., 2015). More frequent abuse of stimulants resulted 
in more severe feelings of depression. This association can be viewed in several ways. Students 
who are depressed may misuse stimulants to improve their mood or improve other aspects of 
their life that are causing them concern, such as academics or social life (Benson et al., 2015). In 
this way, students with depression may self-medicate with illicit stimulants (Benson et al., 2015). 
Historically, stimulants have been used to treat minor cases of depression (Hicks, 2021; 
Rasmussen, 2008). Amphetamines cause a dopamine rush that would feel euphoric to a 
depressed brain and increase functioning for a short period (Kish, 2008; Haile, 2012).  Thus, this 
argument bears some merit and should be thoroughly evaluated. Students suffering from 
depression should be encouraged to seek help, not try to self-medicate. Without the appropriate 
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course of treatment, depression symptoms will not lessen, leading to more complex mental 
health problems and even a mental health crisis.  
 The second argument is that stimulant abuse inadvertently causes depression. The 
association between poor mental health and stimulant abuse is well documented (Benson et al., 
2015; Lueck et al., 2019). Students who have poor mental health are prone to extreme levels of 
anxiety and clinical depression. These same students report increased intent to abuse stimulants 
than their mentally healthy counterparts (Benson et al., 2015; Lueck et al., 2019). It is possible 
then that depression in persons who abuse stimulants is a direct result of misusing a drug that 
increases dopamine levels in individuals who are already prone to depression and anxiety. 
(Benson et al., 2015). Once the stimulant wears off, it leaves users acutely aware that they no 
longer feel the rush of dopamine and serotonin amphetamines provide. This can be a dangerous 
combination for individuals who already struggle with regulating their serotonin and dopamine 
levels.  
Consequences of Stimulant Abuse  
As previously discussed, the problem of stimulant abuse is rapidly increasing and cannot be 
ignored, as there are consequences for both the user and the systems involved. Currently, 
stimulants are the second most abused illicit substance, marijuana being the most used drug for 
college students (Arria et al., 2013; Gomes et al., 2011; Weyandt et al., 2013). Side effects of 
stimulant misuse can range from minor to life-threatening. Ranging from sleeping difficulties 
(Hartung et al., 2013; McCabe et al., 2014; Mulvihill, 2013; Weyandt et al., 2013), headaches 
(McCabe et al., 2014; Mulvihill, 2013), irritability (Hartung et al., 2013; McCabe et al., 2014; 
Weyandt et al., 2013), appetite reduction (Hartung et al., 2013; Mulvihill, 2013; Weyandt et al., 
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2013), and reduced academic self-efficacy (Hartung et al., 2013), to more severe consequences 
like depression (Benson et al., 2015; Chen et al., 2016; Lueck et al., 2019; McCabe et al., 2014), 
seizures (Haak, 2017; Mulvihill, 2013), adverse cardiac outcomes (Chen et al., 2016; Haak, 
2017; Mulvihill, 2013; Varga, 2012), psychiatric comorbidities (Chen et al., 2016; Mulvihill, 
2013; Varga, 2012) and even death (Gomes et al., 2011; Haak, 2017; Varga, 2012). Overdoses 
related to stimulants are becoming increasingly common, which is reflected in the number of 
Emergency Department visits involving stimulants. According to Chen et al. (2016), the number 
of stimulant-related visits tripled from 2005 to 2010, and Haak (2017) claims they increased 
four-fold in the same period. Following this pattern, stimulant overdoses or severe side-effects in 
teenagers rose by 76%, as reported by Poison Control Centers (Chen et al., 2016). 
This alarming rise in stimulant overdoses and adverse side effects is compounded 
because many users do not view stimulants as dangerous. 81% (Weyandt et al., 2016) of students 
who abuse stimulants admit to having very little information about the drug, its dosage, or 
potential side effects (Haak, 2017; Via, 2019). Despite the FDA black box warning, simulants 
are viewed as safe because they are FDA-approved (Weyandt et al., 2013). Stimulant abuse also 
puts users at an increased risk for addiction and co-occurring substance use disorders (Chen et 
al., 2016; Garnier-Dykstra et al., 2012; Gomes et al., 2011; Hartung et al., 2013; Haak, 2017; 
McCabe et al., 2014; Varga, 2012; Via, 2019). Some students chose to take stimulants intra-
nasally, which produces a much stronger reaction to the drug, and thus has more potential for 
addiction (Garnier-Dykstra et al., 2012; Varga, 2012). Most students do not use the medications 
in this way. However, for those that do, there are serious consequences. Intra-nasal 
administration leads to higher levels of addiction and graduating to more illicit substances in 
order to get the high they crave (Via, 2019).  
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Varga’s 2012 literature review shines some light on the seriousness of stimulant abuse by 
using a personal testimony of a student-turned-drug user. “It all started with Ritalin and Adderall. 
I started taking them every day [to get high] and pretty soon it didn’t work anymore and I needed 
something more. I needed a bigger, faster boost” (Varga, 2012). This young man’s experience is 
not abnormal. Adderall abusers are 20 times more likely to experiment with cocaine and heroin 
once their body has built a tolerance to Adderall (Varga, 2012). The cavalier attitude towards 
stimulant abuse cannot continue. Students inadvertently risk their lives taking drugs intended to 
help them study more efficiently.  
Besides the physical consequences of stimulant abuse, there are judicial consequences as 
well. Misusing stimulants is considered a felony in most states and can lead to prison time for 
those caught misusing the medications (Gomes et al., 2011; Hartung et al., 2013; Mulvihill, 
2013; Weyandt et al., 2016). There are also school-mediated consequences for abusing 
stimulants. Most schools define using stimulants without a prescription as cheating, in the same 
vein as looking at another student’s test (Weyandt et al., 2016). Students, however, view using 
stimulants much differently. According to Weyandt et al. (2016), 33% of Ivy League students 
believed that using stimulants was not a form of cheating. 41% thought it should be categorized 
as cheating, and 25% were unsure. There is a discrepancy between understanding the 
consequences of stimulant abuse and the risks perceived by students. The following section 







The key to changing illicit stimulant use will revolve around changing the attitudes 
regarding stimulants’ effectiveness and safety (Garnier-Dykstra et al., 2013; Judson & Langdon, 
2008; Lueck et al., 2019; Mulvihill, 2013; Varga, 2013). The main points of education need to be 
about the ineffectiveness of stimulants as cognitive enhancers and the negative consequences of 
abusing stimulants. Both of these areas of information will be essential in lowering stimulant 
abuse. For example, Looby et al. (2013) examined whether challenging the positive beliefs about 
stimulant abuse would prove efficacious in preventing stimulant abuse long-term. Ninety-six 
high-risk students were chosen to participate after meeting the researcher’s inclusion criteria. 
The term high risk was interpreted as GPA lower than 3.5, Greek involvement, binge drinking, 
and cannabis use for this experiment. The study required two laboratory visits and an online 
survey as a six-month follow-up. At the beginning of the study, all participants received the 
PSEQ-II, a 45 item Likert-type scale that assesses attitudes about stimulant abuse. Using a 
randomized controlled trial design, they assigned students to the control and the experimental 
groups (Looby et al., 2013).  
The experimental group received what they were told was a prescription stimulant 
medication during one visit and no medication during another in order to debunk the positive 
expectancies for stimulant abuse. In contrast, the control group received no intervention during 
either visit. Both groups were asked to complete a series of surveys during their lab visits 
assessing mood, arousal, and a wide range of cognitive abilities. At the end of the second lab 
visit, the experimental group was informed that the pill they took during the first lab session was 
a placebo and then participated in a 30-minute expectancy challenge. This challenge included 
26 
 
assessing students’ attitudes and expectations for stimulant medication and the negative 
consequences of taking stimulants illicitly. Researchers explained in detail that any changes in 
cognitive performance witnessed during the placebo lab visit were purely due to students’ 
expectations that they would perform better while using stimulants (Looby et al., 2013). 
Researchers hypothesized that the students assigned to the expectancy challenge group 
would show a decreased use of stimulants compared with the control group at the six-month 
follow-up. While they did see a change in attitudes toward stimulant abuse at the end of the 
study, the interventions and control group had the same level of prescription stimulant use at the 
six-month follow-up. They concluded that to reduce stimulant abuse, the educational program 
has to include booster sessions regularly and emphasize the negative consequences of using 
stimulants alongside the uselessness of the prescriptions as cognitive enhancers. Ironically, all 
negative attitudes towards stimulants are not equal in their persuasive efforts. Guilt over 
participating in illegal activity and the fear of dependence ranked lower as deterrents than 
unpleasant side effects and long-term health issues. (Looby et al., 2013). 
Guilt and fear as motivating are not universal as motivating factors, but they shed light on 
different areas that need to be targeted for effective education. Gaining the upper hand against 
the stimulant epidemic is going to require a three-pronged approach. Education needs to be 
targeted at students by colleges, medical professionals, and parents to be successful. College-led 
interventions are supported by much of the current literature surrounding prescription stimulant 
abuse (Chen et al., 2016; Garnier-Dykstra et al., 2013; Judson & Langdon, 2008; Looby et al., 
2013; Varga, 2012; Via, 2019). They cannot solve the current problem with stimulant abuse. 
That issue is much more systemic. Nevertheless, they can help alleviate some of the issues with 
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stimulant abuse on their specific campuses. Varga (2012) suggests a framework that college 
campuses can use to help decrease illicit stimulant use.  
Gaining an accurate picture of the problem may be difficult since stimulant abuse is self-
reported, but this is an important step. To address the issue, we need to know how widespread it 
is. First, colleges need to step back and analyze the culture of their campus (Garnier-Dykstra et 
al., 2013; Varga, 2012). The level of acceptance on campus and the risk factors for stimulant 
abuse on their campus must also be examined. During this general assessment, colleges may find 
information about other causative agents on their campus. Things such as competitiveness, 
pressure from professors, poor mental health, and inadequate access to counseling or self-help 
groups can all contribute to stimulant abuse (Varga, 2012). While these findings can be 
disappointing to administrators, addressing them will benefit the college and student health.  
Next, colleges should provide faculty and staff education. Education would include the 
signs and symptoms of stimulant abuse and addressing the topic with students safely and 
effectively. This training would include sessions for all campus faculty and staff. Sessions 
catered to residence hall and library staff should also be included as these are two places where 
transactions often occur. They are the staff most likely to encounter the suspicious behavior and 
mannerisms that often accompany illicit transactions and can help with supervision and 
prevention efforts. Involving the medical and psychiatric staff on campus will be invaluable in 
addressing this issue. We know that poor mental health is often associated with stimulant abuse 
(Benson et al., 2015; Lueck et al., 2019), so communicating with counseling centers about the 
signs and symptoms will be an essential step in preventing abuse. Coaches and the academic 
support staff are also likely to encounter students abusing stimulants. Student-athletes are some 
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of the busiest on campus and may turn to stimulants to help them get through the day (Benson et 
al., 2015; Garnier-Dykstra et al., 2012). These same students often end up on academic probation 
and encounter academic support staff whose goal is to help them stay in school. Both coaches 
and academic support staff provide avenues to address stimulant abuse.  
Finally, education focused on the students themselves can help reduce stimulant abuse 
(Chen et al., 2016; Garnier-Dykstra et al., 2012; Judson & Langdon, 2008; Varga, 2012; Via, 
2019).  As we know from the research done by Looby et al. (2013), students’ perceptions about 
stimulants abuse influence their choices most strongly. Many students perceive stimulants as safe 
with minor consequences for use (Applequist & Ball, 2018; Benson et al., 2015; Chen et al., 
2016; Varga, 2012). We know from previous discussions that this is not the case. Therefore, 
addressing students’ perceptions will need to be a focal point of education (Garnier-Dykstra et 
al., 2012; Judson & Langdon, 2008; Lueck et al., 2019; Varga, 2012; Via, 2019).  
Many colleges have mandatory first-year orientation for students entering college. This 
would be an ideal place to present materials regarding stimulant abuse. These education sessions 
need to address three things. First, it is not safe or legal to take stimulants without a prescription. 
Emphasizing the negative consequences of abusing stimulants and their uselessness as cognitive 
enhancers will be the first step. Detailing the legal and physical consequences of stimulant abuse, 
as well as the college’s policy on academic honesty, is an excellent place to start. Second, 
education should focus on students coming into college with a prescription for stimulants who 
might be asked to divert their medication (Benson et al., 2015; Varga, 2012). Many students are 
unaware that it is illegal to buy, sell, or trade medications, so education on this front may help 
reduce the willingness of students with prescriptions to supply their peers. Having a 
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representative from the Drug Enforcement Administration (DEA) explain that it is illegal to take 
another’s prescription and sell or trade medications may make students more reluctant to divert 
their prescriptions (Varga, 2012). Third, students should be prepared for the academic rigors of 
college and briefed on the resources available to them (Garnier-Dykstra et al., 2012; Varga, 
2012; Weyandt et al., 2016). Many students are not well-prepared for the increase in workload 
when moving from high school to college. It is relatively easy to get by in high school without 
spending much effort or developing good study habits. When these students are confronted by 
their first college course, they are often astounded at the amount of time it takes to master the 
material. Without good study habits, these students flounder and quickly become discouraged by 
the drop in their GPAs (Varga, 2012). This may lead to stimulant abuse to buoy their grade and 
keep pace with the many other claims on their time. One way to mitigate this is to include 
mandatory study sessions as part of class requirements. Many college classes and coaches 
include meeting with tutors as a large part of students’ grades and eligibility. This approach can 
only do so much as a student’s willingness to participate directly affects the outcomes. However, 
these built-in safety nets can help promote a culture of academic honesty and teach students 
prioritization.  
These efforts from colleges to reduce stimulant abuse will be helpful but will not solve 
the problem on their own. Including medical professionals in the fight against stimulant abuse 
will make success much more likely (Garnier-Dykstra et al., 2013; Via, 2019; Weyandt et al., 
2016). Via (2019) outlines how clinicians can play a vital role in helping stop illicit stimulant 
use. “It is important for all providers interacting with patients prescribed stimulants to ask about 
prescribed medication adherence and verify prescriptions each visit via local/state prescription 
and drug monitoring programs.” While lying to a provider about medication adherence is easy, it 
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is not as easy to divert medication when a medication regimen is in place. These medication 
regimens can involve random urine screens to test for concomitant drug use, capping the refills a 
patient can get without a follow-up evaluation, and changing their prescription to a non-stimulant 
if abuse is suspected (Via, 2019). Clinicians must learn to recognize the signs associated with 
stimulant diversion or abuse, such as sensation-seeking behaviors, binge drinking, mental health 
problems, and abnormal physical symptoms such as changes in their appetite, tachycardia, high 
blood pressure, hair loss and twitchiness (Benson et al., 2015). In individuals with a history of a 
substance use disorder, physicians should steer away from prescribing stimulants or implement 
intensive monitoring systems (Garnier-Dykstra et al., 2013; Lueck et al., 2019, Via, 2019). 
Clinicians should also be aware of potential medication-seeking behavior from young adults who 
self-report ADHD symptoms but do not meet the criteria for the disorder when interviewed by 
medical professionals (Garnier-Dykstra et al., 2013).  
However, for physicians to reach their full potential, it is crucial to educate them on the 
importance of their intervention. A study by Wedyandt et al. (2016) found that most primary care 
physicians do not discuss “misuse, diversion, or potential consequences and side effects” of 
stimulant misuse. The reason behind this is that nearly half of all physicians found it difficult or 
uncomfortable to discuss the potential dangers of stimulants with their patients (Wedyandt et al., 
2016). In this situation, it is easy to point the finger at physicians, but realistically, these 
clinicians have never received training on distributing information regarding highly addictive 
medications. Physicians and pediatricians would greatly benefit from training on discussing the 
dangers, consequences, and side effects of medication misuse with patients (Varga, 2012; 
Weyandt et al., 2016). Medical and pharmacy school curricula should include sections on 
prescription abuse and diversion and how to prevent it. These professionals are often required to 
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complete continuing education classes to maintain the currency of their license. Including 
stimulant abuse awareness as one of these topics can help keep stimulant abuse in front of 
clinicians’ minds.  
Finally, parents should be involved in the fight against stimulant abuse (Garnier-Dykstra 
et al., 2013; Varga, 2012; Weyandt et al., 2016). The most recent data (Weyandt et al., 2016) 
suggests that the onset of stimulant abuse peaks in high school. Therefore, children are still 
typically living at home, and parents can pick up on the signs of stimulant abuse. Varga (2012) 
points out that “More often than not, parents know when something is wrong, potentially even 
before the student realizes it.” Having parents involved is also crucial for combatting stimulant 
abuse as parents are often the source of academic pressure (Benson et al., 2015; Garnier-Dykstra 
et al., 2012; Varga, 2012). Informing parents of the health consequences that could be associated 
with pressure to achieve could mediate this issue. Because parents place pressure on their 
children out of love, addressing this will require tactfulness and understanding. Encouraging 
parents to keep conversation lines open with their children and be supportive as they transition to 
college is one-way parents can help decrease their children’s pressure. Making parents aware of 
the difficulties their child may experience adjusting to living away from home and surrounded by 
peers can also help make parents more sensitive to changes in their child’s demeanor (Varga, 
2012).  
Gaps in the Research  
This comprehensive literature review highlights several areas for future research. First, 
while risk factors for stimulant abuse (Applequist & Ball, 2018; Arria et al., 2013; Benson et al., 
2015; Chen et al., 2016; Garnier-Dykstra et al., 2012; Haak, 2017; Hartung et al., 2013; Lueck et 
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al., 2019; Mulvihill, 2013; Varga, 2012) are thoroughly discussed, there is very little research on 
protective factors. Protective factors are defined as “a characteristic at the biological, 
psychological, family, or community (including peers and culture) level that is associated with a 
lower likelihood of problem outcomes or that reduces the negative impact of a risk factor on 
problem outcomes” (O’Connell et al., 2009). Knowing that Greek life, an extracurricular 
activity, is a risk factor for stimulant abuse (Arria et al., 2013; Benson et al., 2015; Garnier-
Dykstra et al., 2012; Hartung et al., 2013; Lueck et al., 2019) it stands to reason that various 
other extracurricular activities could function as protective factors. In this situation, protective 
factors could be healthy study habits, positive parental involvement, or religious affiliation.  
There has been very little research done into protective factors. Knowing these might help 
parents and colleges get students involved in activities that reduce the risk of stimulant abuse.  
Second, knowing why students divert from stimulants is going to be necessary to develop 
policies and programs that can prevent diversion from occurring. While there is research on why 
students abuse stimulants (Diller, 2010; Applequist & Ball, 2018; Arria et al., 2017; Benson et 
al., 2015; Chen et al., 2016; Garnier-Dykstra et al., 2012; Smith & Farah, 2011; Varga, 2012), 
there is not an adequate amount of research on why students divert stimulants. The available 
research focuses on purely qualitative reasons, which leaves much to be desired. It appears most 
students divert their medications to appear socially adept, help out friends, or for financial gain 
(Benson et al., 2015). As Benson et al. (2015) points out, “Studies that rigorously examine 
reasons for diversion using quantitative methods are needed.”  
Third, more research into the cognitive effects of stimulants would help determine 
appropriate strategies to prevent stimulant abuse. Several studies to date address this topic 
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(Benson et al., 2015; Garnier-Dykstra et al., 2012; Smith & Farah, 2011; Varga, 2012), but many 
of these studies observe correlations between the use of stimulants and GPA, which can be 
misleading. As previously discussed, students may find themselves with little time to prepare for 
assignments and use stimulants to cope (Garnier-Dykstra et al., 2012), or these students may 
already experience academic difficulties and use stimulants in the hope that it will keep their 
GPA from dropping even further (Benson et al., 2015). We cannot determine whether stimulants 
effectively prevented a drop in GPA, or if using stimulants to study the night before a test is 
profitable. To test the effects of stimulants on cognitive performance, we would need to have two 
groups of students, one who used stimulants the night before a test to study and the other who 
received a placebo. Experimental double-blind studies could provide beneficial information. At 
this point, no research has been done along these lines. 
Finally, no research has been done on the impact of campus culture on stimulant abuse. 
Because stimulant abuse is a problem primarily found in college students, investigating whether 
specific campus attitudes and policies lead to misuse would be insightful. For example, many 
campuses clearly list the consequences for drug or alcohol abuse but do not mention the 
consequences for stimulant abuse. There are often no consequences for those caught diverting 
stimulants, leading to bolder attitudes about selling or giving their stimulants to friends.  It could 
be that this nonchalance is contributing to misuse on specific campuses. Also, many students 
receive a diagnosis of ADHD while in college. It could be that lax diagnostic processes increase 
the rates of stimulant abuse as well. The recommended diagnostic process currently involves 
obtaining information about the individual’s behavior from multiple sources, ruling out other 
diagnoses, and following a set of objective tests indicating an ADHD diagnosis. Many campus 
practitioners do not follow the recommended diagnostic guidelines for the sake of time (Varga, 
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2012). These poor diagnostic practices can extend to practitioners outside of college campuses 
and begin to affect children and adolescents. Further research is needed on the effects of campus 
policies on stimulant abuse and diversion.  
Application to Nursing 
This research sheds light on a genuine issue that needs to be addressed by today’s 
healthcare and education professionals. It is helpful to view this issue through Nursing Theorist 
Jean Watson’s Philosophy and Science of Caring model. Watson’s model defines health as “a 
high level of overall physical, mental, and social functioning, a general adaptive-maintenance 
level of daily functioning, the absence of illness or the presence of efforts leading to the absence 
of illness” (Watson, 2021). Simply put, health is not just an absence of disease, but achieving a 
level of harmony between physical, mental, and social functioning. In the context of stimulant 
abuse, nurses cannot define health as the absence of addiction or illicit drug use. There are 
motivational factors behind illicit stimulant use that must be explored to help patients reach 
holistic health. Nurses can play a prominent role in stopping illicit stimulant use. 
According to Gallup, nurses have been ranked as the most trusted profession for 19 years 
in a row (Gaines, 2021). This trust places nurses in a unique position to interact with patients in a 
way that physicians may not have. Often, nurses are called upon to be educators for patients and 
families, which opens a window of opportunity to address critical information about drug 
diversion and abuse (Manworren & Gilson, 2015). Nurses have the opportunity to provide newly 
diagnosed patients with cautionary teaching, emphasizing the importance of taking their 
prescription as directed and the consequences of deviating from the prescribed course of 
treatment. New research points to the effectiveness of implementing universal preventative 
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substance abuse plans as soon as patients are prescribed stimulants (Via, 2019). These programs 
attempt to deter prescription stimulant abuse by providing prescription holders with the skills and 
information necessary to prevent abuse, diversion, and addiction (Via, 2019).  
Specifically, we should provide teaching to youth entering high school or college about 
the temptations to view their prescriptions as “study buddies.” Explaining that these medications 
do not provide any cognitive benefits to individuals without an accurate diagnosis of ADHD can 
help decrease the reputation stimulants have as cognitive enhancers. Nurses should also take time 
to educate their patients on the seriousness of diversion (Manworren & Gilson, 2015). 
Medications are prescribed for one person, and to give or sell medications is not only dangerous 
for a nonprescription holder; it is a federal offense. Nurses should be aware of medication-
seeking behaviors when educating patients about their new prescriptions. Healthcare 
professionals should also be observing and screening for risky behavior in general that may 
indicate a pattern. This behavior can present as risky sexual practices, driving under the 
influence, and illegal substance usage (Via, 2019).  
Nurses must ask about medication adherence at all follow-up appointments, and if abuse 
or diversion is suspected, intervene. Indicators of abuse may include requesting medication 
refills earlier than appropriate, claiming to have lost or misplaced their prescription, or asking for 
a different type of stimulant medication (Via, 2019).  If a nurse suspects abuse, conducting 
random urine screens or requesting the provider change the prescription to weekly dosages can 
help prevent problems. Because depression and stimulant abuse can go hand-in-hand (Lueck et 
al., 2019; Benson et al., 2015), nurses should conduct thorough depression screenings on patients 
requesting stimulant medications. Monitoring patients with a history of mental illness for 
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stimulant abuse will be imperative, as will watching for any signs of mental illness, specifically 
signs of depression, in patients using prescription stimulants.  
 We nurses are being called to care for patients in novel ways that stretch and grow their 
knowledge and capabilities. If stimulant abuse is an issue that plagues a part of the population, 
nurses must learn to answer this threat and equip themselves to stand beside their patients. A 
nurses role in preventing stimulant abuse is pivotal, as nurses log the most contact hours with 
patients We may be the only avenue patients have to get the help they need and prevent the next 
health crisis. As Jean Watson says, “Maybe this one moment, with this one person, is the very 
reason we’re here on Earth at this time.” (Watson, 2021).  
Conclusion 
The fight against the stimulant abuse epidemic is not straightforward. Legislation 
addressing the issues of doctor shopping, accessibility, and doubling up on prescriptions could 
help reduce the flow of stimulants onto the market. However, legislation alone will not solve the 
problem. Educating students on the dangers of illicit stimulant use will be important in the fight 
against stimulant abuse. Moreover, changing the attitudes surrounding the effectiveness of 
stimulants as cognitive enhancers may help decrease student abuse. It is unlikely that our world 
will become less competitive; in fact, research points to a continued climb toward unattainable 
standards by the educational system (Varga, 2012). Therefore, educating parents on the 
importance of support, awareness, and honesty with their children, specifically those prescribed 
stimulants, can help students deal with the inevitable academic pressures. Finally, we need to 
examine the education of our healthcare professionals. The opioid epidemic has become a 
widespread problem recognized by healthcare workers and law enforcement. However, it took 
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seventeen years for the medical field to address this epidemic for the systemic issue it proved to 
be. Waiting for the stimulant epidemic to achieve that level of carnage is unacceptable. 
Healthcare professionals need education on the importance of screening measures, the signs of 
stimulant abuse, and how they can help prevent abuse from occurring. Regardless of the tactics 
used to approach this issue, there is no easy, overnight solution. These recommendations will not 
solve the problem but could increase awareness and slow the spread of illicit stimulant use. 
Addressing this issue will require a unified front from colleges, medical professionals, legislative 
bodies, and parents. Changing the future of America’s relationship with stimulants will not be 
without its challenges. Ignoring the issue and continuing in a state of blissful ignorance would be 
much easier. As former President John F. Kennedy once said, “There are risks and costs to a 
program of action, But they are far less than the long-range risks and costs of comfortable 
inaction” (Presential Library and Museum, 2021). This is a fight for the future of America’s 
youth, and a lackadaisical approach will bring no change.   
Project Analysis  
This project was particularly meaningful to me as I have fostered this idea since second 
semester of Junior year. I became interested in the subject after reading several books on the 
increase in pediatric prescriptions the United States has experienced in the last 50 years. I simply 
couldn’t understand how these huge numbers of prescriptions were possible in such young 
patients. Through digging a little deeper I found that stimulant medications, those used to treat 
attention deficit hyperactivity disorder (ADHD), made up one of the largest categories of 
pediatric prescriptions. I knew from our pharmacology course that these medications had a 
somewhat sordid history and was intrigued. I began researching the chemical make-up of 
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stimulants and learned that amphetamines, a category of stimulant, is the chemical cousin to the 
infamous methamphetamine, and produce many of the same feelings and side effects. Once I 
learned this, I was hooked. I began sifting through articles dating back as far as 1967 that 
described the negative effects of stimulant medications and how these prescriptions had been 
misused almost from their conception. From there, my curiosity, and the project grew. I learned 
that these medications were commonly abused by college students with the belief that they 
would help them study longer and harder. I decided to focus on the topic of stimulant abuse for 
my honors research project and nursing research project. There were plenty of publications 
addressing the potential for abuse these mediations held, approximately how many students 
abuse stimulants every year, and the negative health outcomes, but very few outlined 
interventions to prevent stimulant abuse. I found this troubling and set out to discover all 
evidenced backed interventions I could.  
 During the research period of my project, I sifted through hundreds of articles, reading 
abstracts, and expanding my research into new areas. I decided on a literature review structure, 
as I wanted to address so many things in my project. I wanted my literature review to be 
comprehensive, and address the most poignant issues, but I also wanted to address the 
interventions that could help address the issue. During the writing process I was also taking 
public health nursing, a course which opened my eyes to the potential for my research. Stimulant 
abuse is a far-reaching issue and affects more than just the college students abusing these 
medications. I began framing the topic as a public health issue and designated a section of my 
paper to exploring the impact stimulant abuse has on nursing. While portions are set up like a 
typical literature review, others read like a novel. This deviates from the traditional path of 
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research nursing, but I felt it allowed me to reach a greater audience by making the information 
more easily digestible.  
At times, I was incredibly frustrated at the complete lack of concern shown for this issue 
that was becoming passionate about. Surrounded by sticky notes, highlighted text, and scribbled 
notes in the margins of articles I could not understand how the sense of urgency this issue 
invoked in me was not shared by the public. I felt the issue was disregarded by collegiate 
administration, medical professionals, and parents. At times, I felt like my research was 
pointless. After all, none of the research before mine had changed anything about the way the 
system operated. I knew that my presentation and paper would not change the general attitude, 
but I hoped that by adding a new voice to the chorus the issue might become more widely 
known. By the end of my project, I had compiled what I felt was the most relevant information 
on stimulant abuse and formulated a structure to address the issue. This project stretched me in 
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